Androgens play an important role during the development of both normal prostate
epithelium and prostate cancer and variants of genes involved in androgen metabolism may …

Abstract The first ESMO Consensus Conference on prostate cancer was held in Zurich,
Switzerland, on 17–19 November 2011, with the participation of a multidisciplinary panel of …

Evidence indicates that a diet rich in omega (ω)-6 polyunsaturated fatty acids (PUFAs)[eg,
linoleic acid (LA)] increases prostate cancer (PCa) risk, whereas a diet rich in ω-3 decreases …

Hormone therapy remains central to the management of advanced prostate cancer.
Evidence has accrued to suggest benefits from earlier treatment. Trials which demonstrate …

Background: Whether the immunohistochemical expression (IHCE) of the bcl2, the p53 and
of the prostate apoptosis response-4 (PAR4) proteins is associated with preoperative PSA …

Background: Prostate cancer is one of the most common tumors in the world and the fifth
leading cause of male cancer death. Although the treatment of localized androgen …

Prostate cancer is the most common malignant disease and second in causes of cancer
death among men in Western Europe and North America. Despite improved surgical and …

Objective: Biochemical failure after radical prostatectomy (RP) for localized prostate cancer
(PC) is the first evidence of disease recurrence. If residual benign prostatic glands are left …

Radical retropubic prostatectomy (RRP) is the reference method for treatment of localised,
organ confined prostate cancer. Since the introduction of nerve-sparing procedure for RRP …

The prognostic implications of capsular incision (CI) remain to be defined. We evaluated the
impact of CI on biochemical recurrence (BCR) and the potential risk factors of CI. Between …